Skip to main content
Vita 34 AG logo

Vita 34 AG — Investor Relations & Filings

Ticker · V3V ISIN · DE000A0BL849 LEI · 529900OEWA4GSZEZ4P40 F Human health and social work activities
Filings indexed 794 across all filing types
Latest filing 2016-03-30 Annual Report
Country DE Germany
Listing F V3V

About Vita 34 AG

https://www.vita34.de/en/

Vita 34 AG is a biobank specializing in the cryopreservation of stem cells derived from umbilical cord blood and tissue. Established in 1997 as the first private cord blood bank in Europe, the company offers services for the long-term storage of perinatal stem cells for potential future medical applications. The service portfolio includes providing collection kits for childbirth, handling logistics, processing the biological material, and storing the stem cell deposits under cryogenic conditions. These services are offered to expectant parents as a form of private medical provision for their child and family. As part of the Famicord Group, Vita 34 is also involved in research and development related to cell-based therapies.

Recent filings

Filing Released Lang Actions
Annual Report 2015
Annual Report Classification · 100% confidence The document is explicitly titled 'Vita 34 AG Annual Report 2015'. It contains comprehensive financial data, including a balance sheet, income statement, cash flow statement, management board letter, and audit opinion references. It covers the full fiscal year 2015 and provides detailed business analysis, making it a standard Annual Report (10-K equivalent for non-US entities). FY 2015
2016-03-30 English
Jahresfinanzbericht 2015
Annual Report Classification · 100% confidence The document is titled 'Geschäftsbericht 2015' (Annual Report 2015) for Vita 34 AG. It contains comprehensive financial statements (Balance Sheet, Income Statement, Cash Flow), a management report (Konzernlagebericht), a letter from the board, and an audit opinion reference (Bestätigungsvermerk). It is clearly a full annual report, not an announcement or a summary. FY 2015
2016-03-30 German
Report Publication Announcement 2016
Report Publication Announcement Classification · 100% confidence The document is extremely short (1751 characters) and its sole purpose is to announce *when* and *where* future financial reports (Annual financial report and Annual financial report of the group) will be disclosed. It explicitly states: "Vita 34 AG hereby announces that the following financial reports shall be disclosed". This perfectly matches the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports, rather than being the report itself (like a 10-K or IR).
2016-03-23 English
Hinweis auf Jahresfinanzbericht vom 01.01.2015 bis zum 31.12.2015
Report Publication Announcement Classification · 100% confidence The document is a short notification (under 800 characters) informing stakeholders that the Annual Financial Report for the period 01.01.2015 to 31.12.2015 is available for download via a provided URL. It does not contain the actual financial statements or report content, but rather serves as an announcement of the report's publication. Per the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2016-03-23 German
Datum:23.03.2016
Report Publication Announcement Classification · 100% confidence The document is a short notification (757 characters) informing shareholders that the annual financial report for the period 01.01.2015 to 31.12.2015 is available on the company's website. It does not contain the report itself, but rather acts as a formal announcement of its publication. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2016-03-23 German
Vita 34 AG increases Earnings per Share by 81 percent to EUR 0.67 and attains an EBITDA Margin of 27.5 percent
Earnings Release Classification · 100% confidence The document is explicitly labeled as an "Ad-hoc announcement according to § 15 WpHG" and is disseminating "figures on fiscal year 2015 in advance." It provides key preliminary financial metrics (revenues, EPS, EBITDA margin) for the past fiscal year and mentions that the final figures will be published later with the Annual Report. This format—a brief, early release of key financial highlights before the full official report—perfectly matches the definition of an Earnings Release (ER). It is not the full 10-K, nor is it a transcript or a general regulatory filing (RNS), as it has a specific financial reporting purpose. FY 2015
2016-03-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.